Elsevier

Schizophrenia Research

Volume 192, February 2018, Pages 485-486
Schizophrenia Research

Letter to the editor
Is a guideline based treatment cost-effective for a middle income country? Results from a study with Mexican adolescents

https://doi.org/10.1016/j.schres.2017.06.003Get rights and content

Section snippets

Funding

The Child Psychiatric Hospital covered the costs of the study.

Contributors

R.E.U. designed the study and wrote the protocol. T.S. and L.A. collected the information from the patients' charts, R.E.U. and L.A. performed statistical analyses and wrote the first draft. All authors contributed to editing the manuscript.

Acknowledgement

Authors would like to thank Dr. Francisco de la Rosa for his data review contribution.

References (10)

  • R. Ulloa et al.

    Validity and reliability of the spanish version of the personal and social performance scale in adolescents with schizophrenia

    Schizophr. Res.

    (2015)
  • A. Karow et al.

    Cost-effectiveness of 12-month therapeutic assertive community treatment as part of integrated care versus standard care in patients with schizophrenia treated with quetiapine immediate release (ACCESS trial)

    J. Clin. Psychiatry

    (2012)
  • P. McCrone et al.

    Economic evaluation of early intervention services

    Br. J. Psychiatry Suppl.

    (2007)
  • P. Morosini et al.

    Development, reliability and acceptability of a new version of the DSM-IV social and occupational functioning assessment scale (SOFAS) to assess routine social functioning

    Acta Psychiatr. Scand.

    (2000)
  • A. Park et al.

    Early intervention for first-episode psychosis: broadening the scope of economic estimates

    Early Interv. Psychiatry

    (2016)
There are more references available in the full text version of this article.
View full text